Bartter syndrome natural history, complications and prognosis: Difference between revisions
Jump to navigation
Jump to search
TayyabaAli (talk | contribs) No edit summary |
TayyabaAli (talk | contribs) No edit summary |
||
| (15 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
Main article: [[Bartter syndrome|Bartter syndrome]] | |||
{{Bartter syndrome}} | {{Bartter syndrome}} | ||
{{CMG}}{{AE}}{{TAM}} | {{CMG}}{{AE}}{{TAM}} | ||
==Overview== | ==Overview== | ||
Bartter Syndrome usually occurs in childhood. [[Bartter syndrome]] type I and type II are salt-wasting renal tubular disorders that are clinically characterized by [[polyhydramnios]] leading to [[premature delivery]], marked [[polyuria]], and a tendency towards [[nephrocalcinosis]]. Common complications of [[Bartter syndrome]] include [[Gallstones]], [[Rhabdomyolysis]], [[Prolonged QT interval]], Life-threatening [[arrhythmia]], [[Syncope]], [[Sudden death]], weakening of the bones and Renal failure. The limited prognostic information available suggests that early diagnosis and appropriate treatment of infants and young children with classic [[Bartter Syndrome]] (type 3) may improve growth and perhaps neuro-intellectual development. On the other hand, sustained [[hypokalemia]] and [[hyperreninemia]] can cause progressive [[tubulointerstitial nephritis]], resulting in [[end-stage renal disease]] (Kidney failure). With the early treatment of the [[electrolyte]] imbalances, the prognosis for patients with Classic [[Bartter Syndrome]] is good. Patients with [[Bartter syndrome]] type I and II tend to present a satisfactory prognosis after a median follow-up of more than 10 years. | |||
==Natural History== | ==Natural History== | ||
*Bartter Syndrome usually occurs in childhood. Patient presents with the history of: | *Bartter Syndrome usually occurs in childhood. Patient presents with the history of: | ||
**Constipation | **[[Constipation]] | ||
**Growth failure. The rate of weight gain is much lower than that of other children of similar age and gender. | **[[Growth failure]]. The rate of weight gain is much lower than that of other children of similar age and gender. | ||
**Increased urinary frequency. The patient needs to urinate more often than usual. | **Increased [[urinary frequency]]. The patient needs to urinate more often than usual. | ||
**Low blood pressure | **Low blood pressure | ||
**Kidney stones | **[[Nephrolithiasis]] (Kidney stones) | ||
**Muscle cramping and weakness<ref name="urlBartter syndrome: MedlinePlus Medical Encyclopedia">{{cite web |url=https://medlineplus.gov/ency/article/000308.htm |title=Bartter syndrome: MedlinePlus Medical Encyclopedia |format= |work= |accessdate=}}</ref> | **[[Muscle ache|Muscle cramping]] and weakness<ref name="urlBartter syndrome: MedlinePlus Medical Encyclopedia">{{cite web |url=https://medlineplus.gov/ency/article/000308.htm |title=Bartter syndrome: MedlinePlus Medical Encyclopedia |format= |work= |accessdate=}}</ref> | ||
==Complications== | ==Complications== | ||
*[[Bartter syndrome]] type I and type II are salt-wasting renal tubular disorders that are clinically characterized by [[polyhydramnios]] leading to [[premature delivery]], marked [[polyuria]], and a tendency towards [[nephrocalcinosis]].<ref name="pmid18695706">{{cite journal| author=Seyberth HW| title=An improved terminology and classification of Bartter-like syndromes. | journal=Nat Clin Pract Nephrol | year= 2008 | volume= 4 | issue= 10 | pages= 560-7 | pmid=18695706 | doi=10.1038/ncpneph0912 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18695706 }} </ref> | |||
*Bartter syndrome type I and type II are salt-wasting renal tubular disorders that are clinically characterized by polyhydramnios leading to premature delivery, marked polyuria, and a tendency towards nephrocalcinosis.<ref name="pmid18695706">{{cite journal| author=Seyberth HW| title=An improved terminology and classification of Bartter-like syndromes. | journal=Nat Clin Pract Nephrol | year= 2008 | volume= 4 | issue= 10 | pages= 560-7 | pmid=18695706 | doi=10.1038/ncpneph0912 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18695706 }} </ref> | *[[Gallstones]] might represent a new complication of antenatal [[Bartter syndrome]].<ref name="pmid20219833">{{cite journal| author=Puricelli E, Bettinelli A, Borsa N, Sironi F, Mattiello C, Tammaro F | display-authors=etal| title=Long-term follow-up of patients with Bartter syndrome type I and II. | journal=Nephrol Dial Transplant | year= 2010 | volume= 25 | issue= 9 | pages= 2976-81 | pmid=20219833 | doi=10.1093/ndt/gfq119 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20219833 }} </ref> Gallstone formation might result from an altered function of either the sodium–potassium–chloride cotransporter or the channel ROMK within the [[hepatobiliary system]].<ref name="pmid20219833">{{cite journal| author=Puricelli E, Bettinelli A, Borsa N, Sironi F, Mattiello C, Tammaro F | display-authors=etal| title=Long-term follow-up of patients with Bartter syndrome type I and II. | journal=Nephrol Dial Transplant | year= 2010 | volume= 25 | issue= 9 | pages= 2976-81 | pmid=20219833 | doi=10.1093/ndt/gfq119 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20219833 }} </ref> | ||
*Gallstones might represent a new complication of antenatal Bartter syndrome.<ref name="pmid20219833">{{cite journal| author=Puricelli E, Bettinelli A, Borsa N, Sironi F, Mattiello C, Tammaro F | display-authors=etal| title=Long-term follow-up of patients with Bartter syndrome type I and II. | journal=Nephrol Dial Transplant | year= 2010 | volume= 25 | issue= 9 | pages= 2976-81 | pmid=20219833 | doi=10.1093/ndt/gfq119 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20219833 }} </ref> | *[[Hypokalemia]] in [[Bartter syndrome]] can be exacerbated by [[electrolytes]] and fluid losses. [[Diarrhea]], [[vomiting]], [[alcohol abuse]], [[cocaine]], or other drugs result in [[electrolyte]] and fluid loss. Severe [[hypokalemia]] can lead to [[rhabdomyolysis]], [[prolonged QT interval]], life-threatening [[arrhythmia]], [[syncope]], and [[sudden death]].<ref name="pmid23760993">{{cite journal| author=Hacihamdioglu DO, Fidanci K, Kilic A, Gok F, Topaloglu R| title=QT and JT dispersion and cardiac performance in children with neonatal Bartter syndrome: a pilot study. | journal=Pediatr Nephrol | year= 2013 | volume= 28 | issue= 10 | pages= 1969-74 | pmid=23760993 | doi=10.1007/s00467-013-2517-5 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23760993 }} </ref><ref name="pmid17390745">{{cite journal| author=Scognamiglio R, Negut C, Calò LA| title=Aborted sudden cardiac death in two patients with Bartter's/Gitelman's syndromes. | journal=Clin Nephrol | year= 2007 | volume= 67 | issue= 3 | pages= 193-7 | pmid=17390745 | doi=10.5414/cnp67193 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17390745 }} </ref> | ||
*Hypokalemia in Bartter syndrome can be exacerbated by electrolytes and fluid losses. Diarrhea, vomiting, alcohol abuse, cocaine, or other drugs result in electrolyte and fluid loss. Severe hypokalemia can lead to rhabdomyolysis, prolonged QT interval, life-threatening arrhythmia, syncope, and sudden death.<ref name="pmid23760993">{{cite journal| author=Hacihamdioglu DO, Fidanci K, Kilic A, Gok F, Topaloglu R| title=QT and JT dispersion and cardiac performance in children with neonatal Bartter syndrome: a pilot study. | journal=Pediatr Nephrol | year= 2013 | volume= 28 | issue= 10 | pages= 1969-74 | pmid=23760993 | doi=10.1007/s00467-013-2517-5 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23760993 }} </ref><ref name="pmid17390745">{{cite journal| author=Scognamiglio R, Negut C, Calò LA| title=Aborted sudden cardiac death in two patients with Bartter's/Gitelman's syndromes. | journal=Clin Nephrol | year= 2007 | volume= 67 | issue= 3 | pages= 193-7 | pmid=17390745 | doi=10.5414/cnp67193 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17390745 }} </ref> | *[[Glomerular filtration rate]] of <90 mL/min/1.73 m2, sometimes associated with [[proteinuria|overt proteinuria]]. | ||
*Prolonged [[hypokalemia]] can lead to [[interstitial fibrosis]] and tubular atrophy.<ref name="pmid18178802">{{cite journal| author=Reungjui S, Roncal CA, Sato W, Glushakova OY, Croker BP, Suga S | display-authors=etal| title=Hypokalemic nephropathy is associated with impaired angiogenesis. | journal=J Am Soc Nephrol | year= 2008 | volume= 19 | issue= 1 | pages= 125-34 | pmid=18178802 | doi=10.1681/ASN.2007030261 | pmc=2391040 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18178802 }} </ref> | |||
*Large amounts of [[calcium]] are lost through the urine ([[hypercalciuria]]), which can cause weakening of the bones ([[osteopenia]]).<ref name="urlBartter syndrome - Genetics Home Reference - NIH">{{cite web |url=https://ghr.nlm.nih.gov/condition/bartter-syndrome#synonyms |title=Bartter syndrome - Genetics Home Reference - NIH |format= |work= |accessdate=}}</ref> | |||
* Untreated cases are associated with significant morbidity and mortality with a major contribution from [[chronic kidney disease]]. [[Kidney failure]] is a possible complication due to [[interstitial fibrosis]], and may require [[renal]] replacement therapy.<ref name="pmid26140272">{{cite journal| author=Al Shibli A, Narchi H| title=Bartter and Gitelman syndromes: Spectrum of clinical manifestations caused by different mutations. | journal=World J Methodol | year= 2015 | volume= 5 | issue= 2 | pages= 55-61 | pmid=26140272 | doi=10.5662/wjm.v5.i2.55 | pmc=4482822 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26140272 }} </ref> | |||
==Prognosis== | ==Prognosis== | ||
*The limited prognostic information available suggests that early diagnosis and appropriate treatment of infants and young children with classic Bartter Syndrome (type 3) may improve growth and perhaps neuro-intellectual development. On the other hand, sustained hypokalemia and hyperreninemia can cause progressive tubulointerstitial nephritis, resulting in end-stage renal disease (Kidney failure). With the early treatment of the electrolyte imbalances, the prognosis for patients with Classic Bartter Syndrome is good. | *The prognosis is based on mutations or depends on the degree of the receptor dysfunction.<ref name="pmid26140272">{{cite journal| author=Al Shibli A, Narchi H| title=Bartter and Gitelman syndromes: Spectrum of clinical manifestations caused by different mutations. | journal=World J Methodol | year= 2015 | volume= 5 | issue= 2 | pages= 55-61 | pmid=26140272 | doi=10.5662/wjm.v5.i2.55 | pmc=4482822 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26140272 }} </ref> | ||
*Patients with Bartter syndrome type I and II tend to present a satisfactory prognosis after a median follow-up of more than 10 years.<ref name="pmid20219833">{{cite journal| author=Puricelli E, Bettinelli A, Borsa N, Sironi F, Mattiello C, Tammaro F | display-authors=etal| title=Long-term follow-up of patients with Bartter syndrome type I and II. | journal=Nephrol Dial Transplant | year= 2010 | volume= 25 | issue= 9 | pages= 2976-81 | pmid=20219833 | doi=10.1093/ndt/gfq119 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20219833 }} </ref> | *The limited prognostic information available suggests that early diagnosis and appropriate treatment of infants and young children with classic [[Bartter Syndrome]] (type 3) may improve growth and perhaps neuro-intellectual development. On the other hand, sustained [[hypokalemia]] and [[hyperreninemia]] can cause progressive [[tubulointerstitial nephritis]], resulting in [[end-stage renal disease]] (Kidney failure). With the early treatment of the [[electrolyte]] imbalances, the prognosis for patients with Classic [[Bartter Syndrome]] is good. | ||
*Patients with [[Bartter syndrome]] type I and II tend to present a satisfactory prognosis after a median follow-up of more than 10 years.<ref name="pmid20219833">{{cite journal| author=Puricelli E, Bettinelli A, Borsa N, Sironi F, Mattiello C, Tammaro F | display-authors=etal| title=Long-term follow-up of patients with Bartter syndrome type I and II. | journal=Nephrol Dial Transplant | year= 2010 | volume= 25 | issue= 9 | pages= 2976-81 | pmid=20219833 | doi=10.1093/ndt/gfq119 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20219833 }} </ref> | |||
==References== | ==References== | ||
Latest revision as of 20:17, 5 August 2020
Main article: Bartter syndrome
|
Bartter syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Bartter syndrome natural history, complications and prognosis On the Web |
|
American Roentgen Ray Society Images of Bartter syndrome natural history, complications and prognosis |
|
FDA on Bartter syndrome natural history, complications and prognosis |
|
CDC on Bartter syndrome natural history, complications and prognosis |
|
Bartter syndrome natural history, complications and prognosis in the news |
|
Blogs on Bartter syndrome natural history, complications and prognosis |
|
Risk calculators and risk factors for Bartter syndrome natural history, complications and prognosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Tayyaba Ali, M.D.[2]
Overview
Bartter Syndrome usually occurs in childhood. Bartter syndrome type I and type II are salt-wasting renal tubular disorders that are clinically characterized by polyhydramnios leading to premature delivery, marked polyuria, and a tendency towards nephrocalcinosis. Common complications of Bartter syndrome include Gallstones, Rhabdomyolysis, Prolonged QT interval, Life-threatening arrhythmia, Syncope, Sudden death, weakening of the bones and Renal failure. The limited prognostic information available suggests that early diagnosis and appropriate treatment of infants and young children with classic Bartter Syndrome (type 3) may improve growth and perhaps neuro-intellectual development. On the other hand, sustained hypokalemia and hyperreninemia can cause progressive tubulointerstitial nephritis, resulting in end-stage renal disease (Kidney failure). With the early treatment of the electrolyte imbalances, the prognosis for patients with Classic Bartter Syndrome is good. Patients with Bartter syndrome type I and II tend to present a satisfactory prognosis after a median follow-up of more than 10 years.
Natural History
- Bartter Syndrome usually occurs in childhood. Patient presents with the history of:
- Constipation
- Growth failure. The rate of weight gain is much lower than that of other children of similar age and gender.
- Increased urinary frequency. The patient needs to urinate more often than usual.
- Low blood pressure
- Nephrolithiasis (Kidney stones)
- Muscle cramping and weakness[1]
Complications
- Bartter syndrome type I and type II are salt-wasting renal tubular disorders that are clinically characterized by polyhydramnios leading to premature delivery, marked polyuria, and a tendency towards nephrocalcinosis.[2]
- Gallstones might represent a new complication of antenatal Bartter syndrome.[3] Gallstone formation might result from an altered function of either the sodium–potassium–chloride cotransporter or the channel ROMK within the hepatobiliary system.[3]
- Hypokalemia in Bartter syndrome can be exacerbated by electrolytes and fluid losses. Diarrhea, vomiting, alcohol abuse, cocaine, or other drugs result in electrolyte and fluid loss. Severe hypokalemia can lead to rhabdomyolysis, prolonged QT interval, life-threatening arrhythmia, syncope, and sudden death.[4][5]
- Glomerular filtration rate of <90 mL/min/1.73 m2, sometimes associated with overt proteinuria.
- Prolonged hypokalemia can lead to interstitial fibrosis and tubular atrophy.[6]
- Large amounts of calcium are lost through the urine (hypercalciuria), which can cause weakening of the bones (osteopenia).[7]
- Untreated cases are associated with significant morbidity and mortality with a major contribution from chronic kidney disease. Kidney failure is a possible complication due to interstitial fibrosis, and may require renal replacement therapy.[8]
Prognosis
- The prognosis is based on mutations or depends on the degree of the receptor dysfunction.[8]
- The limited prognostic information available suggests that early diagnosis and appropriate treatment of infants and young children with classic Bartter Syndrome (type 3) may improve growth and perhaps neuro-intellectual development. On the other hand, sustained hypokalemia and hyperreninemia can cause progressive tubulointerstitial nephritis, resulting in end-stage renal disease (Kidney failure). With the early treatment of the electrolyte imbalances, the prognosis for patients with Classic Bartter Syndrome is good.
- Patients with Bartter syndrome type I and II tend to present a satisfactory prognosis after a median follow-up of more than 10 years.[3]
References
- ↑ "Bartter syndrome: MedlinePlus Medical Encyclopedia".
- ↑ Seyberth HW (2008). "An improved terminology and classification of Bartter-like syndromes". Nat Clin Pract Nephrol. 4 (10): 560–7. doi:10.1038/ncpneph0912. PMID 18695706.
- ↑ 3.0 3.1 3.2 Puricelli E, Bettinelli A, Borsa N, Sironi F, Mattiello C, Tammaro F; et al. (2010). "Long-term follow-up of patients with Bartter syndrome type I and II". Nephrol Dial Transplant. 25 (9): 2976–81. doi:10.1093/ndt/gfq119. PMID 20219833.
- ↑ Hacihamdioglu DO, Fidanci K, Kilic A, Gok F, Topaloglu R (2013). "QT and JT dispersion and cardiac performance in children with neonatal Bartter syndrome: a pilot study". Pediatr Nephrol. 28 (10): 1969–74. doi:10.1007/s00467-013-2517-5. PMID 23760993.
- ↑ Scognamiglio R, Negut C, Calò LA (2007). "Aborted sudden cardiac death in two patients with Bartter's/Gitelman's syndromes". Clin Nephrol. 67 (3): 193–7. doi:10.5414/cnp67193. PMID 17390745.
- ↑ Reungjui S, Roncal CA, Sato W, Glushakova OY, Croker BP, Suga S; et al. (2008). "Hypokalemic nephropathy is associated with impaired angiogenesis". J Am Soc Nephrol. 19 (1): 125–34. doi:10.1681/ASN.2007030261. PMC 2391040. PMID 18178802.
- ↑ "Bartter syndrome - Genetics Home Reference - NIH".
- ↑ 8.0 8.1 Al Shibli A, Narchi H (2015). "Bartter and Gitelman syndromes: Spectrum of clinical manifestations caused by different mutations". World J Methodol. 5 (2): 55–61. doi:10.5662/wjm.v5.i2.55. PMC 4482822. PMID 26140272.